Dr. Reddy's Laboratories Balance Sheet
NYSE: RDYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dr. Reddy's Laboratories financial position
At the end of fiscal 2025, Dr. Reddy's Laboratories reported total assets of $5.77 billion, up 24.1% from a year earlier against total liabilities of $1.82 billion. Shareholders' equity stood at $3.90 billion, or 67.6% of assets. The company held $172.0 million in cash and equivalents against $547.0 million of debt, a net debt position of $375.0 million.
The current ratio (current assets divided by current liabilities) was 1.92, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.14.
Summary generated from market data by MetaCap's automated system. Methodology
Dr. Reddy's Laboratories balance sheet (annual)
| Fiscal year (USD) | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 172.00M | 85.00M | 70.00M | 196.00M | 203.00M | 27.00M | 32.00M | 41.00M |
| Short-Term Investments | 506.00M | 892.00M | 682.00M | 389.00M | 270.00M | 314.00M | 326.00M | 282.00M |
| Receivables | 1.06B | 963.00M | 882.00M | 880.00M | 679.00M | 667.00M | 576.00M | 624.00M |
| Inventory | 832.00M | 763.00M | 592.00M | 671.00M | 621.00M | 465.00M | 486.00M | 447.00M |
| Total Current Assets | 2.93B | 2.98B | 2.52B | 2.40B | 2.03B | 1.73B | 1.66B | 1.68B |
| Property, Plant & Equipment | 1.14B | 923.00M | 809.00M | 819.00M | 781.00M | 694.00M | 782.00M | 889.00M |
| Goodwill | 138.00M | 51.00M | 52.00M | 58.00M | 62.00M | 53.00M | 56.00M | 61.00M |
| Intangible Assets | 1.13B | 443.00M | 375.00M | 359.00M | 487.00M | 367.00M | 642.00M | 686.00M |
| Total Assets | 5.77B | 4.65B | 3.92B | 3.86B | 3.63B | 3.08B | 3.26B | 3.46B |
| Accounts Payable | 417.00M | 371.00M | 322.00M | 337.00M | 325.00M | 221.00M | 210.00M | 247.00M |
| Short-Term Debt | 455.00M | 169.00M | 148.00M | 370.00M | 328.00M | 275.00M | 237.00M | 392.00M |
| Total Current Liabilities | 1.53B | 1.15B | 1.04B | 1.24B | 1.14B | 966.00M | 863.00M | 1.07B |
| Long-Term Debt | 92.00M | 72.00M | 16.00M | 76.00M | 86.00M | 17.00M | 318.00M | 385.00M |
| Total Liabilities | 1.82B | 1.28B | 1.11B | 1.35B | 1.26B | 1.02B | 1.23B | 1.52B |
| Shareholders' Equity | 3.90B | 3.37B | 2.81B | 2.51B | 2.37B | 2.06B | 2.03B | 1.94B |
| Retained Earnings | 3.70B | 3.18B | 2.62B | 2.32B | 2.13B | 1.91B | 1.86B | 1.75B |
| Total Debt | 547.00M | 241.00M | 164.00M | 446.00M | 414.00M | 292.00M | 555.00M | 777.00M |
| Net Cash (Debt) | 131.00M | 736.00M | 588.00M | 139.00M | 59.00M | 49.00M | -197.00M | -454.00M |
| Shares Outstanding | 832.64M | 830.78M | 829.79M | 165.73M | 165.78M | 165.85M | 165.91M | 165.74M |
This table shows 8 annual periods of Dr. Reddy's Laboratories's balance sheet, from FY 2025 back to FY 2018, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow RDY's reporting calendar. What is a balance sheet?